News | Clinical Decision Support | March 11, 2015

Point of Care Decision Support Anticoagulation Software Helps Reduce Hospital Re-Admissions

Software is designed and developed in association with national patient safety guidelines to reduce adverse events and re-admissions

Point of Care Decision Support, anticoagulation software, PCDS AC, therapy

Image courtesy of Point of Care Decision Support


March 11, 2015 — Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and reduces adverse events associated with anticoagulation therapy. The software was designed and developed in collaboration with leading clinical thrombosis experts, and is a decision support tool that takes the complexity out of AC management by providing a real-time AC dashboard. With intuitive, predictive clinical decision support, PCDS AC transforms evidence-based guidelines into intelligent tools that measure and improve AC therapy outcomes.

PCDS AC meets the key recommendations of The Joint Commission, the Centers for Medicare and Medicaid Services (CMS) and the Anticoagulation EHR (Electronic Health Record) Task Force. The system could be beneficial in light of new target-specfic oral anticoagulants (TSOAC) drugs coming onto the market, changing AC therapy protocols and more stringent regulatory guidelines.

Key benefits and outcomes of using PCDS AC include:

Patient Safety and Cost Savings: Warfarin-related adverse drug events (myocardial infarctions, strokes, major bleeds, etc.) are reduced by consistently achieving time-in-therapeutic range (TTR) above 70 percent per CMS recommendations.

Patient Safety & Revenue Generation: The PCDS AC system brings together the ACCP Antithrombotic guidelines, risk ratings like CHA2DS2-VASc, HAS-BLED, HEMORR2HAGES, drug-drug interactions, and other evidence-based research to automatically identify high risk patients and manage their AC care end-to-end.  This also provides an opportunity to identify new patients who may benefit from proactive AC therapy and reduce their overall risk of stroke.

Patient Satisfaction: The PCDS AC system incorporates full TSOAC therapy and workflow, which allow for expanded paradigms of anticoagulant management. These new TSOAC agents require far less blood testing, which is a major benefit for patients.  In addition, the system provides data on the efficacy of TSOACs, leading to improved patient care and, ultimately, cost savings surrounding adverse events.

Fulfill CMS Meaningful Use Stages 2 & 3: Provides ability to fulfill CMS MU-2 criteria for quality of Warfarin dosing at a system level with TTR > 70 percent.  Achieves MU-3 measures by improving population health, provides decision support for high priority health conditions, and provides patient self-management tools via a mobile patient engagement application.

Point of Care Decision Support provides any healthcare organization a free, customized demonstration and business case report for its anticoagulant patient population. 

For more information: www.ptofcare.com


Related Content

News | Clinical Decision Support

May 22, 2025 — Auxira Health has officially launched — the company provides a new approach to clinical support purpose ...

Home May 23, 2025
Home
News | Clinical Decision Support

December 7, 2022 — Compared with team-based care alone, the addition of a computerized clinical decision support system ...

Home December 07, 2022
Home
News | Clinical Decision Support

July 18, 2019 — On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins ...

Home July 18, 2019
Home
News | Clinical Decision Support

February 11, 2019 — The American College of Cardiology (ACC), along with nine other cardiology professional societies ...

Home February 11, 2019
Home
News | Clinical Decision Support

October 23, 2018 — Health informatics company Impathiq announced its Heart Pathway point-of-care clinical decision ...

Home October 23, 2018
Home
Technology | Clinical Decision Support

April 30, 2018 — Point of Care Decision Support (PCDS) announced the release of a new version 2.0 of their ...

Home April 30, 2018
Home
Technology | Clinical Decision Support

February 14, 2018 — The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact ...

Home February 14, 2018
Home
Feature | Clinical Decision Support

January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader in ...

Home January 18, 2018
Home
News | Clinical Decision Support

October 16, 2017 — The American College of Cardiology (ACC), along with several partnering societies, recently released ...

Home October 16, 2017
Home
News | Clinical Decision Support

October 11, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR ...

Home October 11, 2017
Home
Subscribe Now